norfloxacin
Selected indexed studies
- Norfloxacin versus alternative antibiotics for prophylaxis of spontaneous bacteria peritonitis in cirrhosis: a systematic review and meta-analysis. (BMC Infect Dis, 2023) [PMID:37641014]
- Norfloxacin: its potential in clinical practice. (Am J Med, 1987) [PMID:3300309]
- Norfloxacin: a quinoline antibiotic. (Drug Intell Clin Pharm, 1986) [PMID:3516615]
_Worker-drafted node — pending editorial review._
Connections
norfloxacin is a side effect of
Sources
- Norfloxacin versus alternative antibiotics for prophylaxis of spontaneous bacteria peritonitis in cirrhosis: a systematic review and meta-analysis. (2023) pubmed
- Norfloxacin: its potential in clinical practice. (1987) pubmed
- Norfloxacin: a quinoline antibiotic. (1986) pubmed
- Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. (1985) pubmed
- Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity. (1987) pubmed
- Effects of norfloxacin exposure on neurodevelopment of zebrafish (Danio rerio) embryos. (2019) pubmed
- Norfloxacin: a new targeted fluoroquinolone antimicrobial agent. (1988) pubmed
- Norfloxacin: clinical pharmacology and clinical use. (1987) pubmed
- Paeoniflorin combined with norfloxacin ameliorates drug-resistant Streptococcus suis infection. (2022) pubmed
- Norfloxacin-induced hepatitis. (1993) pubmed